NCT01067976View on ClinicalTrials.gov

Efficacy and Safety of Gadobutrol 1.0 Molar (Gadovist) for Breast MRI

PHASE3CompletedINTERVENTIONAL
Enrollment

446

Participants

Timeline

Start Date

February 28, 2010

Primary Completion Date

July 31, 2011

Study Completion Date

January 31, 2012

Conditions
Breast CancerDiagnostic Imaging
Interventions
DRUG

Gadobutrol (Gadavist, Gadovist, BAY86-4875)

A single bolus injection of gadobutrol 1.0 M 0.1mmol/kg body weight

Trial Locations (40)

3010

Bern

5404

Baden

7000

Chur

14467

Potsdam

20097

San Donato Milanese

20132

Milan

20141

Milan

22649

Rio de Janeiro

23538

Lübeck

30625

Hanover

33100

Udine

33521

Tampere

35033

Marburg

39120

Magdeburg

44263

Dortmund

45147

Essen

45257

Essen

62781

Springfield II

72076

Tübingen

78229

San Antonio

80131

Napoli

90033

Los Angeles

92093

La Jolla

92658-6100

Newport Beach

20007-2197

Washington D.C.

02118

Boston

C1082A

Buenos Aires

C1181ACH

Buenos Aires

C1425BEE

Buenos Aires

05651-901

São Paulo

Unknown

São Paulo

Medellín

Bogotá

Barranquilla

Bielefeld

00180

Helsinki

425-021

Ansan Si, Kyungki Do

135-710

Seoul

138-736

Seoul

150-713

Seoul

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY